Back to Browse Journals » Orthopedic Research and Reviews » Volume 4

Rationale, characteristics, and clinical performance of the OsteoSponge®: a novel allograft for treatment of osseous defects

Authors Miller LE, Jacofsky DJ, Kirker KR, Fitzpatrick KL, Juda GA, Block JE

Published Date April 2012 Volume 2012:4 Pages 9—17

DOI http://dx.doi.org/10.2147/ORR.S29397

Received 22 December 2011, Accepted 2 March 2012, Published 3 April 2012

Larry E Miller1,2, David J Jacofsky3, Kelly R Kirker4, Kristin L Fitzpatrick5, Gregory A Juda6, Jon E Block2

1Miller Scientific Consulting, Arden, NC, USA; 2Jon Block Group, San Francisco, CA, USA; 3CORE Institute, Phoenix, AZ, USA; 4Center for Biofilm Engineering, Bozeman, MT, USA; 5Department of Biological Structure, University of Washington, Seattle, WA, USA; 6Bacterin International, Belgrade, MT, USA

Abstract: A variety of bone grafts and bone graft substitutes, each with distinctly different characteristics, is available to the orthopedic surgeon for various reconstructive procedures. However, adequate reconstruction of osseous defects remains a therapeutic challenge. Each bone graft option has a unique set of benefits and risks that must be considered in relation to the particular pathology, and to patient characteristics and comorbidities, in order to achieve the best possible outcome. The OsteoSponge® allograft consists of 100% demineralized human cancellous bone, with no additional carrier materials. The OsteoSponge is compressible, allowing precise graft placement in most osseous defects; subsequent expansion completely fills the void. The material is prepared using methods that preserve native growth factors, thereby promoting cellular ingrowth, proliferation, and ultimately osteogenesis. Preliminary evidence suggests that the OsteoSponge matrix is safe and effective when used in surgical treatment of osseous defects. This article describes the rationale for, and characteristics of, the OsteoSponge, and summarizes the results from preclinical and human studies.

Keywords: allograft, bone graft, demineralized bone, osseous defect, OsteoSponge

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other articles by this author:

Facial fat grafting with a prototype injection control device

Hetherington HE, Block JE

Clinical, Cosmetic and Investigational Dermatology 2013, 6:201-209

Published Date: 13 September 2013

Axial lumbar interbody fusion: a 6-year single-center experience

Zeilstra DJ, Miller LE, Block JE

Clinical Interventions in Aging 2013, 8:1063-1069

Published Date: 12 August 2013

TranS1 VEO system: a novel psoas-sparing device for transpsoas lumbar interbody fusion

Hardenbrook MA, Miller LE, Block JE

Medical Devices: Evidence and Research 2013, 6:91-95

Published Date: 4 June 2013

The KineSpring® Knee Implant System: an implantable joint-unloading prosthesis for treatment of medial knee osteoarthritis

Clifford AG, Gabriel SM, O’ Connell M, Lowe D, Miller LE, Block JE

Medical Devices: Evidence and Research 2013, 6:69-76

Published Date: 17 May 2013

Successful two-stage revision of a KineSpring® joint unloading implant: a case study

Bowditch M, Miller LE, Block JE

International Medical Case Reports Journal 2012, 5:91-95

Published Date: 12 December 2012

Facet-sparing lumbar decompression with a minimally invasive flexible MicroBlade Shaver® versus traditional decompression: quantitative radiographic assessment

Lauryssen C, Berven S, Mimran R, Summa C, Sheinberg M, Miller LE, Block JE

Clinical Interventions in Aging 2012, 7:257-266

Published Date: 20 July 2012

Clinical utility of ultrasound guidance for intra-articular knee injections: a review

Berkoff DJ, Miller LE, Block JE

Clinical Interventions in Aging 2012, 7:89-95

Published Date: 20 March 2012

Percutaneous vertebral augmentation for painful osteolytic vertebral metastasis: a case report

Anselmetti GC, Tutton SM, Facchini FR, Miller LE, Block JE

International Medical Case Reports Journal 2012, 5:13-17

Published Date: 20 March 2012

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010